Canada
· Delayed Price · Currency is CAD Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 216.80 million. The enterprise value is 797.48 million.
| Market Cap | 216.80M |
| Enterprise Value | 797.48M |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 355.41 million shares outstanding. The number of shares has increased by 4.38% in one year.
| Current Share Class | 337.97M |
| Shares Outstanding | 355.41M |
| Shares Change (YoY) | +4.38% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 2.09% |
| Owned by Institutions (%) | 14.13% |
| Float | 332.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| PB Ratio | 0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.44 |
| P/OCF Ratio | 1.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.06, with an EV/FCF ratio of 5.29.
| EV / Earnings | -6.63 |
| EV / Sales | 0.80 |
| EV / EBITDA | 3.06 |
| EV / EBIT | 5.76 |
| EV / FCF | 5.29 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 1.72.
| Current Ratio | 2.75 |
| Quick Ratio | 1.77 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 3.56 |
| Debt / FCF | 6.15 |
| Interest Coverage | 1.61 |
Financial Efficiency
Return on equity (ROE) is -18.52% and return on invested capital (ROIC) is 5.64%.
| Return on Equity (ROE) | -18.52% |
| Return on Assets (ROA) | 4.42% |
| Return on Invested Capital (ROIC) | 5.64% |
| Return on Capital Employed (ROCE) | 7.70% |
| Revenue Per Employee | 345,616 |
| Profits Per Employee | -41,473 |
| Employee Count | 2,900 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.83 |
Taxes
In the past 12 months, Cresco Labs has paid 66.39 million in taxes.
| Income Tax | 66.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.23% in the last 52 weeks. The beta is 1.56, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -71.23% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 1.40 |
| Relative Strength Index (RSI) | 25.95 |
| Average Volume (20 Days) | 658,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 1.00 billion and -120.27 million in losses. Loss per share was -0.35.
| Revenue | 1.00B |
| Gross Profit | 492.12M |
| Operating Income | 138.53M |
| Pretax Income | -39.50M |
| Net Income | -120.27M |
| EBITDA | 219.98M |
| EBIT | 138.53M |
| Loss Per Share | -0.35 |
Balance Sheet
The company has 223.30 million in cash and 928.13 million in debt, giving a net cash position of -704.84 million or -1.98 per share.
| Cash & Cash Equivalents | 223.30M |
| Total Debt | 928.13M |
| Net Cash | -704.84M |
| Net Cash Per Share | -1.98 |
| Equity (Book Value) | 539.82M |
| Book Value Per Share | 1.88 |
| Working Capital | 284.45M |
Cash Flow
In the last 12 months, operating cash flow was 181.78 million and capital expenditures -30.94 million, giving a free cash flow of 150.84 million.
| Operating Cash Flow | 181.78M |
| Capital Expenditures | -30.94M |
| Free Cash Flow | 150.84M |
| FCF Per Share | 0.42 |
Margins
Gross margin is 49.10%, with operating and profit margins of 13.82% and -12.00%.
| Gross Margin | 49.10% |
| Operating Margin | 13.82% |
| Pretax Margin | -3.94% |
| Profit Margin | -12.00% |
| EBITDA Margin | 21.95% |
| EBIT Margin | 13.82% |
| FCF Margin | 15.05% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -55.48% |
| FCF Yield | 69.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.18 |
| Piotroski F-Score | 6 |